Vasoactive intestinal peptide, the major mediator of the WDHA (pancreatic cholera) syndrome: value of measurement in diagnosis and treatment.
D007516:Adenoma, Islet Cell / Q000150:complications* / Q000175:diagnosis; D000328:Adult; D000818:Animals; D002648:Child; D003967:Diarrhea / Q000097:blood* / Q000188:drug therapy / Q000209:etiology; D004285:Dogs; D005768:Gastrointestinal Hormones / Q000097:blood*; D006801:Humans; D007421:Intestine, Small / Q000187:drug effects; D010190:Pancreatic Neoplasms / Q000150:complications* / Q000175:diagnosis; D013311:Streptozocin / Q000627:therapeutic use; D013552:Swine; D013577:Syndrome; D014660:Vasoactive Intestinal Peptide / Q000097:blood* / Q000302:isolation & purification / Q000494:pharmacology
D005768:Gastrointestinal Hormones; D014660:Vasoactive Intestinal Peptide; D013311:Streptozocin